■ 英語タイトル：Negative Pressure Wound Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
	■ 発行会社/調査会社：IMARC ■ 商品コード：IMARC23JLY180 ■ 発行日：2023年7月 ■ 調査対象地域：グローバル ■ 産業分野：医療 ■ ページ数：144 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール

Market Overview:

The global negative pressure wound therapy market size reached US$ 2,658 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 3,582 Million by 2028, exhibiting a growth rate (CAGR) of 5% during 2023-2028.

The negative pressure wound therapy (NPWT), or vacuum-assisted closure, refers to a therapeutic technique used to treat chronic wounds, infections and burns through a vacuum dressing. It is also used for treating diabetic ulcers, pressure ulcers, skin flaps and grafts. It involves a sealed wound dressing attached to a pump that creates negative pressure in and around the wound to increase the blood flow and draw out excess fluid. This aids in the formation of granulation tissue, enhancing the blood flow and wound contraction while minimizing edema and preventing external contamination.

The increasing prevalence of chronic lifestyle disorders, such as diabetes and obesity, is one of the key factors driving the growth of the market. In line with this, the growing geriatric population, which is more susceptible to such medical ailments, is also contributing to the market growth. The rising incidences of diabetes mellitus are acting as another major growth-inducing factor. Diabetes mellitus is one of the most common causes of arterial and diabetic foot ulcers, which are treated using NPWT devices. Additionally, the increasing utilization of technologically advanced single-use NPWT devices is also providing a boost to the market growth. In comparison to the traditionally used tools, these devices are disposable, portable and highly cost-effective and can also be used for providing healthcare at home, thereby eliminating the need for prolonged hospital stays. Apart from this, the production of multi-wound NPWT devices and the development of dynamic pressure control and leak detection systems are contributing to the market growth. Other factors, including improving healthcare infrastructure, along with extensive research and development (R&D) activities, are projected to drive the market further.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global negative pressure wound therapy market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on device, component, wound type, indication and end-user.

Breakup by Device:
Conventional NPWT Devices
Single-Use NPWT Devices
Accessories

Breakup by Component:
Canisters and Dressings
Pumps

Breakup by Wound Type:
Chronic Wounds
Acute Wounds

Breakup by Indication:
Surgical and Traumatic Wounds
Pressure Ulcers
Venous Ulcers
Diabetic Foot Ulcers
Burns
Others

Breakup by End-User:
Hospitals and Clinics
Ambulatory Surgical Centers
Home Care Settings
Others

Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Acelity, Cardinal Health Inc., Carilex Medical Inc., ConvaTec Group PLC, Deroyal, Genadyne Biotechnologies Inc., Lohmann & Rauscher International GmbH & Co. Kg, Medela, Mölnlycke Health Care AB (A Subsidiary of Investor AB), Smith & Nephew, Talley Group, etc.

Key Questions Answered in This Report:
How has the global negative pressure wound therapy market performed so far and how will it perform in the coming years?
What are the key regional markets?
What has been the impact of COVID-19 on the global negative pressure wound therapy market?
What is the breakup of the market based on the device?
What is the breakup of the market based on the component?
What is the breakup of the market based on the wound type?
What is the breakup of the market based on the indication?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global negative pressure wound therapy market and who are the key players?
What is the degree of competition in the industry?

■ 英語タイトル：Eye Care Surgical Market Report by Product (Implants and Stents, Laser Surgery Device, Phacoemulsification Equipment, Viscoelastics), Application (Cataract Surgery, Oculoplastic Surgery, Vitreo-Retinal Surgery, Corneal Surgery, Refractive Surgery, Glaucoma Surgery, and Others), End User (Hospitals, Ophthalmology Clinics, Eye Research Institutes, Ambulatory Surgical Centers), and Region 2023-2028

■ 発行会社/調査会社：IMARC ■ 商品コード：IMARC23JLY176 ■ 発行日：2023年7月 ■ 調査対象地域：グローバル ■ 産業分野：医療 ■ ページ数：135 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール

Market Overview:

The global eye care surgical market size reached US$ 6.24 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.56 Billion by 2028, exhibiting a growth rate (CAGR) of 5.50% during 2023-2028. The rising aging population, growing incidence of eye diseases, increasing awareness and access to healthcare, constant lifestyle changes, and stringent government initiatives and insurance coverage schemes represent some of the key factors driving the market.

Eye care surgical refers to a branch of medicine that focuses on surgical procedures aimed at diagnosing, treating, and correcting various conditions and diseases affecting the eyes. It encompasses a wide range of surgical interventions performed by ophthalmologists, specialized medical professionals who specialize in eye care. Eye care surgical procedures can address a multitude of conditions, including cataracts, glaucoma, refractive errors (such as nearsightedness, farsightedness, and astigmatism), corneal disorders, retinal diseases, and eye injuries. Some commonly performed eye care surgical procedures include cataract surgery, which involves the removal of the cloudy lens and implantation of an artificial lens; laser refractive surgery, such as LASIK or PRK, which reshapes the cornea to correct refractive errors; glaucoma surgery, which aims to reduce intraocular pressure to prevent optic nerve damage; and retinal surgery, which repairs retinal detachments, macular holes, or diabetic retinopathy. The use of precision instruments, lasers, and microsurgical techniques has improved surgical outcomes, reduced complications, and shortened recovery times. Eye care surgical procedures are typically performed in specialized surgical centers or hospitals with dedicated ophthalmology departments. The procedures require highly skilled ophthalmic surgeons who undergo extensive training and possess expertise in specific surgical techniques.

Eye Care Surgical Market Trends:
One of the primary factors driving the market is the increase in the elderly population, leading to a higher prevalence of age-related eye conditions, such as cataracts, glaucoma, and macular degeneration, as these conditions often require surgical intervention for treatment and vision restoration. Additionally, the growing incidence of eye diseases also drives the need for surgical interventions to prevent vision loss and maintain or improve visual function. Other than this, the rising awareness about eye health and play a vital role in accelerating the adoption of eye care surgical procedures. Efforts to educate the public about eye diseases, regular eye examinations, and the effectiveness of surgical treatments have contributed to increased patient awareness and acceptance of surgical interventions. Apart from this, the development of minimally invasive techniques, such as small incision cataract surgery and minimally invasive glaucoma surgery, has allowed for faster healing and improved patient comfort. Moreover, improved access to healthcare facilities, particularly in emerging economies, has led to greater availability of eye care surgical services, further driving market growth. Furthermore, modern lifestyles characterized by increased digital device usage, prolonged screen time, and exposure to environmental factors such as pollution and ultraviolet radiation also impact eye health. These factors have contributed to the development of eye conditions, including dry eye syndrome and refractive errors, which may require surgical intervention for effective treatment and correction.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global eye care surgical market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on the product, application, and end user.

Product Insights:
Implants and Stents
Laser Surgery Device
Phacoemulsification Equipment
Viscoelastics

The report has provided a detailed breakup and analysis of the eye care surgical market based on the product. This includes Implants and stents, laser surgery device, phacoemulsification equipment and viscoelastics. According to the report, implants and stents represented the largest segment.

Application Insights:
Cataract Surgery
Oculoplastic Surgery
Vitreo-Retinal Surgery
Corneal Surgery
Refractive Surgery
Glaucoma Surgery
Others

A detailed breakup and analysis of the eye care surgical market based on the application has also been provided in the report. This includes cataract surgery, oculoplastic surgery, vitreo-retinal surgery, corneal surgery, refractive surgery, glaucoma surgery, and others. According to the report, cataract surgery accounted for the largest market share.

End User Insights:
Hospitals
Ophthalmology Clinics
Eye Research Institutes
Ambulatory Surgical Centers

A detailed breakup and analysis of the eye care surgical market based on the end user has also been provided in the report. This includes hospitals, ophthalmology clinics, eye research institutes, and ambulatory surgical centers. According to the report, hospitals accounted for the largest market share.

Regional Insights:
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for eye care surgical market . Some of the factors driving the North America eye care surgical market included aging population and prevalence of eye disorders, technological advancements in surgical techniques and equipment, increasing focus on vision correction and aesthetic procedures, etc.

Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global eye care surgical market. Detailed profiles of all major companies have been provided. Some of the companies covered include Alcon Inc., Bausch + Lomb (Bausch Health Companies Inc.), BVI Holding Limited, Carl Zeiss Meditec AG (Carl Zeiss AG), Glaukos Corporation, iSTAR Medical, Lumenis Be Ltd., Nidek Co. Ltd., Sight Sciences, Ziemer Ophthalmic Systems AG, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Market Overview:
The global eye care surgical market size reached US$ 6.24 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.56 Billion by 2028, exhibiting a growth rate (CAGR) of 5.50% during 2023-2028. The rising aging population, growing incidence of eye diseases, increasing awareness and access to healthcare, constant lifestyle changes, and stringent government initiatives and insurance coverage schemes represent some of the key factors driving the market.

Eye care surgical refers to a branch of medicine that focuses on surgical procedures aimed at diagnosing, treating, and correcting various conditions and diseases affecting the eyes. It encompasses a wide range of surgical interventions performed by ophthalmologists, specialized medical professionals who specialize in eye care. Eye care surgical procedures can address a multitude of conditions, including cataracts, glaucoma, refractive errors (such as nearsightedness, farsightedness, and astigmatism), corneal disorders, retinal diseases, and eye injuries. Some commonly performed eye care surgical procedures include cataract surgery, which involves the removal of the cloudy lens and implantation of an artificial lens; laser refractive surgery, such as LASIK or PRK, which reshapes the cornea to correct refractive errors; glaucoma surgery, which aims to reduce intraocular pressure to prevent optic nerve damage; and retinal surgery, which repairs retinal detachments, macular holes, or diabetic retinopathy. The use of precision instruments, lasers, and microsurgical techniques has improved surgical outcomes, reduced complications, and shortened recovery times. Eye care surgical procedures are typically performed in specialized surgical centers or hospitals with dedicated ophthalmology departments. The procedures require highly skilled ophthalmic surgeons who undergo extensive training and possess expertise in specific surgical techniques.

Eye Care Surgical Market Trends:
One of the primary factors driving the market is the increase in the elderly population, leading to a higher prevalence of age-related eye conditions, such as cataracts, glaucoma, and macular degeneration, as these conditions often require surgical intervention for treatment and vision restoration. Additionally, the growing incidence of eye diseases also drives the need for surgical interventions to prevent vision loss and maintain or improve visual function. Other than this, the rising awareness about eye health and play a vital role in accelerating the adoption of eye care surgical procedures. Efforts to educate the public about eye diseases, regular eye examinations, and the effectiveness of surgical treatments have contributed to increased patient awareness and acceptance of surgical interventions. Apart from this, the development of minimally invasive techniques, such as small incision cataract surgery and minimally invasive glaucoma surgery, has allowed for faster healing and improved patient comfort. Moreover, improved access to healthcare facilities, particularly in emerging economies, has led to greater availability of eye care surgical services, further driving market growth. Furthermore, modern lifestyles characterized by increased digital device usage, prolonged screen time, and exposure to environmental factors such as pollution and ultraviolet radiation also impact eye health. These factors have contributed to the development of eye conditions, including dry eye syndrome and refractive errors, which may require surgical intervention for effective treatment and correction.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global eye care surgical market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on the product, application, and end user.

Product Insights:

Implants and Stents
Laser Surgery Device
Phacoemulsification Equipment
Viscoelastics

The report has provided a detailed breakup and analysis of the eye care surgical market based on the product. This includes Implants and stents, laser surgery device, phacoemulsification equipment and viscoelastics. According to the report, implants and stents represented the largest segment.

Application Insights:

Cataract Surgery
Oculoplastic Surgery
Vitreo-Retinal Surgery
Corneal Surgery
Refractive Surgery
Glaucoma Surgery
Others

A detailed breakup and analysis of the eye care surgical market based on the application has also been provided in the report. This includes cataract surgery, oculoplastic surgery, vitreo-retinal surgery, corneal surgery, refractive surgery, glaucoma surgery, and others. According to the report, cataract surgery accounted for the largest market share.

End User Insights:

Hospitals
Ophthalmology Clinics
Eye Research Institutes
Ambulatory Surgical Centers

A detailed breakup and analysis of the eye care surgical market based on the end user has also been provided in the report. This includes hospitals, ophthalmology clinics, eye research institutes, and ambulatory surgical centers. According to the report, hospitals accounted for the largest market share.

Regional Insights:

North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for eye care surgical market . Some of the factors driving the North America eye care surgical market included aging population and prevalence of eye disorders, technological advancements in surgical techniques and equipment, increasing focus on vision correction and aesthetic procedures, etc.

Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global eye care surgical market. Detailed profiles of all major companies have been provided. Some of the companies covered include Alcon Inc., Bausch + Lomb (Bausch Health Companies Inc.), BVI Holding Limited, Carl Zeiss Meditec AG (Carl Zeiss AG), Glaukos Corporation, iSTAR Medical, Lumenis Be Ltd., Nidek Co. Ltd., Sight Sciences, Ziemer Ophthalmic Systems AG, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:
How has the global eye care surgical market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global eye care surgical market?
What is the impact of each driver, restraint, and opportunity on the global eye care surgical market?
What are the key regional markets?
Which countries represent the most attractive eye care surgical market?
What is the breakup of the market based on the product?
Which is the most attractive product in the eye care surgical market?
What is the breakup of the market based on the application?
Which is the most attractive application in the eye care surgical market?
What is the breakup of the market based on the end user?
Which is the most attractive end user in the eye care surgical market?
What is the competitive structure of the global eye care surgical market?
Who are the key players/companies in the global eye care surgical market?

■ 英語タイトル：Epinephrine Autoinjector Market by Dosage (0.15mg Epinephrine Autoinjector, 0.3mg Epinephrine Autoinjector, 0.5mg Epinephrine Autoinjector), Application (Under 6 Years, 6 to 12 Years, Over 12 Years), End User (Hospitals, Clinics, and Others), and Region 2023-2028
	■ 発行会社/調査会社：IMARC ■ 商品コード：IMARC23JLY174 ■ 発行日：2023年7月 ■ 調査対象地域：グローバル ■ 産業分野：医療機器 ■ ページ数：146 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール

Market Overview:

The global epinephrine autoinjector market size reached US$ 2.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.4 Billion by 2028, exhibiting a growth rate (CAGR) of 9.40% during 2023-2028. The increasing number of individuals with allergies, rising need for self-administrating medicines, and the launch of smart epinephrine autoinjector represent some of the key factors driving the market.

Epinephrine autoinjector is a medical device used to administer single dose epinephrine easily for treating severe allergic reactions caused by stings, bug bites, or drugs. It is designed to deliver the medication into the thigh muscle of an individual and works by constricting blood vessels and dilating the airways to minimize the symptoms of an allergic reaction. It is small and easy to carry and can be administered by individuals or healthcare professionals. At present, leading manufacturers are introducing epinephrine autoinjector with multiple doses of medications and adjustable dosages that enable the user to adjust the dose according to the severity of the allergic reaction and improve the effectiveness of the treatment. They are also incorporating audio and visual instructions to make it easier for individuals to use them in an emergency.

Epinephrine Autoinjector Market Trends:
The increasing number of individuals with allergies and allergic reactions and the rising need for self-administrating medicines represent one of the major factors driving the demand for epinephrine autoinjectors around the world. Moreover, the surging prevalence of arthritis, asthma, cancer, and chronic obstructive pulmonary disease (COPD) and the growing aging population, which is more prone to develop allergic reactions, is influencing the market positively. In addition, the increasing incidence of food allergies among the masses is bolstering the growth of the market. Apart from this, governing agencies of numerous countries are undertaking initiatives to promote the use of epinephrine autoinjectors in schools and other public spaces. This, coupled with the rising awareness about epinephrine autoinjectors, is contributing to the market growth. Furthermore, key players are introducing smart epinephrine autoinjectors that are integrated with advanced technologies, including Bluetooth connectivity, sensors, and machine learning, to make them more convenient, user friendly, and effective. Leading players are also launching mobile applications that can be connected to smartphones or other devices, allowing remote monitoring, tracking of usage and expiration dates, and ensuring the patient does not exceed the recommended dosage. These advancements can also help predict the likelihood of an allergic reaction and provide personalized recommendations for treatment. This, along with the incorporation of an automated external defibrillator (AED) in epinephrine autoinjectors to offer a comprehensive emergency response system, is creating a positive outlook for the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global epinephrine autoinjector market, along with forecasts at the global, regional, and country level from 2023-2028. Our report has categorized the market based on dosage, application, and end user.

Dosage Insights:
0.15mg Epinephrine Autoinjector
0.3mg Epinephrine Autoinjector
0.5mg Epinephrine Autoinjector

The report has provided a detailed breakup and analysis of the epinephrine autoinjector market based on the dosage. This includes 0.15mg epinephrine autoinjector, 0.3mg epinephrine autoinjector, and 0.5mg epinephrine autoinjector. According to the report, 0.3mg epinephrine autoinjector represented the largest segment.

Application Insights:
Under 6 Years
6 to 12 Years
Over 12 Years

A detailed breakup and analysis of the epinephrine autoinjector market based on the application has also been provided in the report. This includes under 6 years, 6 to 12 years, and over 12 years. According to the report, 6 to 12 years represented the largest segment.

End User Insights:
Hospitals
Clinics
Others

The report has provided a detailed breakup and analysis of the epinephrine autoinjector market based on the end user. This includes hospitals, clinics, and others. According to the report, hospitals represented the largest segment.

Regional Insights:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for epinephrine autoinjectors. Some of the factors driving the North America epinephrine autoinjector market included the rising prevalence of allergies, increasing awareness about anaphylaxis, and the availability of cost-effective generic versions of autoinjectors.

Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global epinephrine autoinjector market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Adamis Pharmaceuticals Corporation, Amneal Pharmaceuticals Inc., Antares Pharma Inc, Bausch Health, Kaleo Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:
How has the global epinephrine autoinjector market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global epinephrine autoinjector market?
What is the impact of each driver, restraint, and opportunity on the global epinephrine autoinjector market?
What are the key regional markets?
Which countries represent the most attractive epinephrine autoinjector markets?
What is the breakup of the market based on the dosage?
Which is the most attractive dosage in the epinephrine autoinjector market?
What is the breakup of the market based on the application?
Which is the most attractive application in the epinephrine autoinjector market?
What is the breakup of the market based on the end user?
Which is the most attractive end user in the epinephrine autoinjector market?
What is the competitive structure of the global epinephrine autoinjector market?
Who are the key players/companies in the global epinephrine autoinjector market?

■ 英語タイトル：Enzymes Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
	■ 発行会社/調査会社：IMARC ■ 商品コード：IMARC23JLY173 ■ 発行日：2023年7月 ■ 調査対象地域：グローバル ■ 産業分野：医療 ■ ページ数：147 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール

Market Overview:

The global enzymes market size reached US$ 12.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 18.1 Billion by 2028, exhibiting a growth rate (CAGR) of 6.06% during 2023-2028.

Enzymes are biological catalysts that accelerate the rate of a chemical reaction in the cell. They help build metabolism and break down fats, proteins and carbohydrates to support digestion. They also assist in building muscles, nerve function, and removing toxins from the body. In addition, they aid in the conservation and transformation of chemical energy, construction of cellular macromolecules from smaller precursors, and prevention of diseases, such as albinism and phenylketonuria. As enzymes are used in the fermenting of wine, leavening of bread, curdling of cheese, and brewing of beer, they find extensive applications in food and beverage (F&B), bioenergy, pharmaceutical, and biotechnology industries across the globe.

Enzymes Market Trends:
The growing demand for enzymes in the pharmaceutical industry to synthesize intermediates in active pharmaceutical ingredient (API) production for effective medications represents one of the key factors driving the market. Moreover, there is a rise in the utilization of enzymes in the food and beverage (F&B) industry to convert starch into glucose. This, along with the increasing application of enzymes in protein engineering technology, is strengthening the growth of the market. In addition, there is a rise in the employment of enzymes to produce biofuels as it is less energy-intensive and more environmental-friendly. This, coupled with the growing demand for renewable energy sources like biofuels, is positively influencing the market. Besides this, the escalating demand for enzymes in detergents to remove fats and oil stains is offering lucrative growth opportunities to industry investors. Apart from this, the rising usage of enzymes in the paper and pulp industry to improve bleaching properties is projected to bolster the growth of the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global enzymes market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, source, reaction type and application.

Breakup by Type:
Protease
Carbohydrase
Lipase
Polymerase and Nuclease
Others

Breakup by Source:
Microorganisms
Plants
Animals

Breakup by Reaction Type:
Hydrolase
Oxidoreductase
Transferase
Lyase
Others

Breakup by Application:
Food and Beverages
Household Care
Bioenergy
Pharmaceutical and Biotechnology
Feed
Others

Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Advanced Enzyme Technologies Limited, Amano Enzyme Inc., Associated British Foods plc, Aumgene Biosciences, BASF SE, Chr. Hansen Holding A/S, Codexis Inc., DuPont de Nemours Inc., Koninklijke DSM N.V., Novozymes A/S, Novus International Inc. (Mitsui & Co. Ltd.) and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:
How has the global enzymes market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global enzymes market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the source?
What is the breakup of the market based on the reaction type?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global enzymes market and who are the key players?
What is the degree of competition in the industry?

■ 英語タイトル：Mouth Ulcer Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
	■ 発行会社/調査会社：IMARC ■ 商品コード：IMARC23JLY165 ■ 発行日：2023年7月 ■ 調査対象地域：グローバル ■ 産業分野：医療 ■ ページ数：140 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール

Market Overview:

The global mouth ulcer treatment market size reached US$ 1.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.2 Billion by 2028, exhibiting a growth rate (CAGR) of 3.3% during 2023-2028.

Mouth ulcers are painful sores that can appear in the mouth. They can be painful and can make it uncomfortable for an individual to eat, drink or brush his/her teeth. While they’re uncomfortable, most mouth ulcers are usually harmless and can clear up by themselves within a couple of days to a fortnight. They are normally round or oval sores that usually appear inside the mouth on the cheeks, lips and tongue. Mouth ulcers can be white, red, yellow or grey in colour and swollen.

Some of the major factors which are leading to mouth ulcers include stress, infection, injury, allergy, unhealthy lifestyles such as high consumption of junk foods and tobacco, etc. Catalyzed by a rising incidence of mouth ulcers, the market for mouth ulcer treatment is also undergoing strong growth. Factors such as rising awareness on modern treatment options, increasing geriatric population, availability of rapid healing and easy to use products, etc., are also creating a positive impact on the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global mouth ulcer treatment market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on formulation, drug class and indication.

Breakup by Formulation:
Gel
Spray
Mouthwash
Lozenges

Based on the formulation, the market has been segmented as gel, spray, mouthwash and lozenges.

Breakup by Drug Class:
Corticosteroids
Anesthetics
Analgesics
Antimicrobials
Antihistamines

On the basis of drug class, corticosteroids represents the largest segment. Other segments include anesthetics, analgesics, antimicrobials and antihistamines.

Breakup by Indication:
Aphthous Stomatitis
Oral Lichen Planus
Others

Based on the indication, the market has been segmented into aphthous stomatitis, oral lichen planus and others.

Breakup by Region:
North America
Europe
Asia Pacific
Middle East and Africa
Latin America

Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Competitive Landscape:
The competitive landscape of the market has also been examined with some of the key players being Blistex Inc, Church & Dwight Co. Inc., 3M, Colgate-Palmolive Company, GlaxoSmithKline, Plc., Bristol Myers Squibb Company, and Pfizer Inc.

This report provides a deep insight into the global mouth ulcer treatment market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the mouth ulcer treatment industry in any manner.

Key Questions Answered in This Report:
How has the global mouth ulcer treatment market performed so far and how will it perform in the coming years?
What are the key regional markets in the global mouth ulcer treatment industry?
What has been the impact of COVID-19 on the global mouth ulcer treatment industry?
What is the breakup of the global mouth ulcer treatment market on the basis of formulation?
What is the breakup of the global mouth ulcer treatment market on the basis of drug class?
What is the breakup of the global mouth ulcer treatment market on the basis of indication?
What are the various stages in the value chain of the global mouth ulcer treatment market?
What are the key driving factors and challenges in the global mouth ulcer treatment market?
What is the structure of the global mouth ulcer treatment market and who are the key players?
What is the degree of competition in the global mouth ulcer treatment market?

■ 英語タイトル：Minimally Invasive Surgery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
	■ 発行会社/調査会社：IMARC ■ 商品コード：IMARC23JLY162 ■ 発行日：2023年7月 ■ 調査対象地域：グローバル ■ 産業分野：医療 ■ ページ数：147 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール

Market Overview:

The global minimally invasive surgery market size reached US$ 49.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 73.8 Billion by 2028, exhibiting a growth rate (CAGR) of 6.6% during 2023-2028.

A minimally invasive surgery utilizes surgical techniques that limit the size and number of cuts or incisions during an operation with the help of small tools, cameras and lights. This procedure is much safer in nature as compared to traditional open surgery as it results in fewer complications, quicker recovery, minimal blood loss, good results and shorter hospital stays. Due to these factors, these surgeries are gaining popularity amongst surgeons as well as patients all over the world. They are mostly being used for cardiothoracic, orthopedic, vascular and neurological surgical procedures.

Market Drivers:
Rising geriatric population across the globe coupled with the increasing prevalence of arthritis, cancer and cardiovascular diseases is impelling the demand for these surgeries as they are associated with fewer risks and minimal procedural trauma.
These procedures are now being performed with the help of robotic technology which allows precise control over the surgery. This has resulted in higher success rates of these procedures which, in turn, is bolstering the market growth.
Technologically advanced products, such as narrow-band imaging endoscopes, and HD cameras have been introduced by manufacturers which are creating a positive outlook for the industry worldwide.
As these surgeries aid in reducing post-operative pain and offer fast recovery, numerous surgeons are now performing them in their own clinics. Therefore, the rising number of physician-owned ambulatory surgical centers (ASCs) is providing impetus to the market growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global minimally invasive surgery market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on product type, application and end-user.

Breakup by Product Type:
Surgical Devices
Laparoscopy Devices
Monitoring and Visualization Devices

Breakup by Application:
Bariatric Surgery
Breast Surgery
Cardiac Surgery
Cosmetic Surgery
Gastrointestinal Surgery
Gynaecological Surgery
Orthopedics and Spine Surgery
Thoracic Surgery
Others

Breakup by End-User:
Hospitals
Clinics
Others

Breakup by Region:
North America
Europe
Asia Pacific
Middle East and Africa
Latin America

Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Zimmer Biomet Inc., Medtronic Inc., GE Healthcare, Intuitive, Eximis Surgical, Stryker Corporation, Arthrex, B. Braun, Bauer Medical, Check-Cap, Cook Medical, OmniGuide, Inc., Orthofix Holdings,Inc, Pentax, Philips Healthcare, RF System, Smith & Nephew, TransEnterix, Virtual Ports, etc.

Key Questions Answered in This Report:
How has the global minimally invasive surgery market performed so far and how will it perform in the coming years?
What are the key regional markets in the global minimally invasive surgery industry?
What has been the impact of COVID-19 on the global minimally invasive surgery industry?
What is the breakup of the market based on the product type?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the global minimally invasive surgery industry?
What are the key driving factors and challenges in the global minimally invasive surgery industry?
What is the structure of the global minimally invasive surgery industry and who are the key players?
What is the degree of competition in the global minimally invasive surgery industry?
What are the profit margins in the global minimally invasive surgery industry?